Luc BuéeProf. Dr.,
Luc Buée is a French scientist (CNRS Research Director). Head of the Inserm laboratory « Alzheimer & Tauopathies » at the Jean-Pierre Aubert Research Centre, University of Lille-North of France. He has worked on Alzheimer’s and related diseases for more than twenty years.
Luc started his work on the role of proteoglycans in Alzheimer's disease with a Ph.D. training at Mount Sinai Medical Center, NYC. He was then involved in the initial characterization of tau aggregates among neurodegenerative disorders. He is currently studying experimental models to better understand tau pathology. His group is also involved in different international consortia.
Jeffrey CummingsProf. Dr.,
Professor of Neurology and Psychiatry; Director Alzheimer Disease Research Center David Geffen School of Medicine at UCLA; member on the GRECC Advisory Committee.
Joris WinderickxProf. Dr.,
Joris Winderickx is an expert cell biologist. He co-founded reMYND together with Fred Van Leuven, Stefaan Wera and Paul Van Dun. After a post-doc at the U. Washington, Seattle, in the Dept. of Genetics and Dept. of Human Genetics, Joris became full professor at the University of Leuven where he heads the Functional Biology group (http://www.kuleuven.be/bio/funbio). The research in his team is focused on the elucidation of signal transduction mechanisms required to control cellular metabolism, growth and survival. This led to the development of so-called humanized yeast models allowing to study crucial aspects related to a variety of human pathologies in a less complex but biologically relevant model system.
Joris was recently appointed as chairman and coordinator of LBioSCENTer, an association of the University of Leuven laboratories with dedicated research on bioscience, bioengineering and biotechnology (http://www.kuleuven.be/bioscenter). He also co-founded the Royal Flemish Society of Chemistry-section Biotechnology and the alumni-association Science@Leuven.
Christopher A. LipinskiDr.,
Christopher Lipinski is a member of the American Chemical Society (ACS), the American Association of Pharmaceutical Sciences (AAPS) and the Society for Biomolecular Sciences (SBS). He is the author of the “rule of five” a widely used filter to select for acceptable drug oral absorption and is a member of the ACS “Medicinal Chemistry Hall of Fame”.
In 2006 he received an honorary law degree from the University of Dundee and won the SBS Achievement Award. In 2005 he won the ACS E. B. Hershberg Award for Important Discoveries in Medicinally Active Substances and in 2004 won the ACS Division of Medicinal Chemistry Award. An adjunct faculty member at the University of Massachusetts Amherst, he has over 235 publications and invited presentations and 17 issued US patents.
Wolfgang OertelProf. Dr.,
Professor at the Department of Neurology, Philipps-University, Marburg, Germany; Chair of the Movement Disorder Society, European Section.
Werner PoeweProf. Dr.,
Werner Poewe is Professor of Neurology and Director of the Department of Neurology at Innsbruck Medical University in Innsbruck, Austria since 1995. Professor Poewe's main research interests are in the field of movement disorders with particular emphasis on the clinical pharmacology of Parkinson's disease and dystonia.
Werner has authored and co-authored more than 550 original articles and reviews in the field of movement disorders. He served as President of the International Movement Disorder Society from 2000 through 2002, as President of the Austrian Society of Neurology from 2002 to 2004 and is the Past President of the Austrian Parkinson's Disease Society.